Tudor Investment Corp’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$988K Sell
108,377
-34,537
-24% -$315K ﹤0.01% 1105
2025
Q1
$1.14M Buy
+142,914
New +$1.14M ﹤0.01% 987
2024
Q3
Sell
-29,963
Closed -$325K 1969
2024
Q2
$325K Buy
29,963
+16,666
+125% +$181K ﹤0.01% 1282
2024
Q1
$249K Sell
13,297
-16,641
-56% -$312K ﹤0.01% 1269
2023
Q4
$649K Sell
29,938
-20,726
-41% -$449K 0.01% 1058
2023
Q3
$1.04M Buy
50,664
+29,841
+143% +$614K 0.01% 895
2023
Q2
$979K Sell
20,823
-10,500
-34% -$494K 0.01% 916
2023
Q1
$1.31M Buy
+31,323
New +$1.31M 0.02% 799
2022
Q4
Sell
-17,207
Closed -$674K 1911
2022
Q3
$674K Sell
17,207
-19,958
-54% -$782K 0.01% 984
2022
Q2
$1.2M Buy
+37,165
New +$1.2M 0.03% 722
2021
Q1
Sell
-4,978
Closed -$431K 1786
2020
Q4
$431K Buy
+4,978
New +$431K 0.01% 998
2020
Q3
Sell
-5,207
Closed -$217K 1498
2020
Q2
$217K Buy
+5,207
New +$217K 0.01% 995
2020
Q1
Sell
-8,166
Closed -$590K 1287
2019
Q4
$590K Buy
+8,166
New +$590K 0.03% 662
2018
Q3
Sell
-5,341
Closed -$836K 1217
2018
Q2
$836K Buy
+5,341
New +$836K 0.03% 489
2018
Q1
Sell
-1,408
Closed -$232K 1194
2017
Q4
$232K Sell
1,408
-3,407
-71% -$561K 0.01% 912
2017
Q3
$300K Buy
4,815
+1,860
+63% +$116K 0.01% 816
2017
Q2
$235K Buy
+2,955
New +$235K 0.01% 825
2016
Q4
Sell
-15,449
Closed -$711K 1562
2016
Q3
$711K Buy
15,449
+6,076
+65% +$280K 0.02% 542
2016
Q2
$282K Buy
+9,373
New +$282K 0.01% 1045
2015
Q3
Sell
-3,131
Closed -$229K 1649
2015
Q2
$229K Buy
+3,131
New +$229K 0.01% 1234